Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 58,976 | 66,090 | N/A | N/A |
| TOTAL | $61,723 | $66,668 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 3,391 | 3,411 | N/A | N/A |
| Other Non-Current Assets | 584 | 723 | 0 | 0 |
| TOTAL | $3,975 | $4,134 | $N/A | $N/A |
| Total Assets | $65,698 | $70,802 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 3,376 | 2,830 | 0 | 0 |
| Accrued Expenses | 1,305 | 2,394 | N/A | N/A |
| Other current liabilities | 19 | 3 | N/A | N/A |
| TOTAL | $11,052 | $6,713 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 709 | 4,007 | 0 | 0 |
| TOTAL | $709 | $4,007 | $N/A | $N/A |
| Total Liabilities | $11,761 | $10,720 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 7 | 6 | N/A | N/A |
| Retained earnings | -109,347 | -59,073 | N/A | N/A |
| Other shareholders' equity | 160,310 | 117,810 | 0 | 0 |
| TOTAL | $53,937 | $60,082 | $N/A | $N/A |
| Total Liabilities And Equity | $65,698 | $70,802 | $0 | $0 |